Bloomberg
- Business
Merck wins Chinese obesity drug in nearly $2 billion deal
Merck will win an exclusive global license to Chinese drugmaker Hansoh’s HS-10535, an investigational oral drug targeting the GLP-1 receptor.…
Read More » - Business
China’s private factory index returned to growth in signs of stability
China’s manufacturing activity expanded for the second straight month, according to a private survey, a further sign of stabilization after…
Read More » - Business
Meta said app stores should Australian police ban social activities under 16 years old
Australia will push for a social media ban for under-16s despite calls from Meta Platforms Inc. to consider shifting responsibility…
Read More » - Business
JPMorgan cancels China stock buy recommendation due to ‘Tariff War 2.0’
JPMorgan Chase & Co. has cut its buy recommendation on Chinese stocks, citing increased volatility around the upcoming U.S. election…
Read More »